Sherwin B. Menopause: myths and realities. Stotland NL, Stewart DE, eds. Psychological Aspects of Women's Health Care: The Interface Between Psychiatry and Obstetrics and Gynecology. 2nd ed. Arlington, Va: American Psychiatric Publishing; 2001. 241-59.
Spinelli MG. Depression and hormone therapy. Clin Obstet Gynecol. 2004 Jun. 47(2):428-36. [Medline].
Soares CN, Taylor V. Effects and Management of the Menopausal Transition in Women With Depression and Bipolar Disorder. J Clin Psychiatry. 2007. 68 (suppl 9):16-21. [Medline].
Baram D. Physiology and symptoms of menopause. Steward DE, Robinson GE, eds. A Clinician's Guide to Menopause. Washington, DC: Health Press International; 1997. 9-28.
Butler L, Santoro N. The reproductive endocrinology of the menopausal transition. Steroids. 2011 Jun. 627-35. [Medline].
Santoro N, Randolph JF Jr. Reproductive hormones and the menopause transition. Obstet Gynecol Clin North Am. 2011 Sep. 455-66. [Medline].
Soares CN. Perimenopause-related mood disturbance: an update on risk factors and novel treatment strategies available. Meeting Program and Abstracts. Psychopharmacology and Reproductive Transitions Symposium. American Psychiatric Association 157th Annual Meeting; May 1-6, 2004; New York, NY. Arlington, Va: American Psychiatric Publishing; 2004. 51-61.
Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and Menopausal Status as Predictors of Depression in Women in Transition to Menopause. Arch Gen Psychiatry. Jan 2004. 61, no. 1:62-70. [Medline].
Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas. 2002 Jul 25. 42(3):195-200. [Medline].
Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006 Apr. 63(4):385-90. [Medline].
Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, et al. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry. 2015 Mar 1. 172 (3):227-36. [Medline].
Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, Gold EB, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry. 2010 Jun. 67(6):598-607. [Medline].
Soares CN, Joffe H, Steiner M. Menopause and mood. Clin Obstet Gynecol. 2004 Sep. 47(3):576-91. [Medline].
Jehan S, Masters-Isarilov A, Salifu I, Zizi F, Jean-Louis G, Pandi-Perumal SR, et al. Sleep Disorders in Postmenopausal Women. J Sleep Disord Ther. 2015 Aug. 4 (5):[Medline].
Murphy PJ, Cambell SS. Sex hormones, sleep, and core body temperature in older postmenopausal women. Sleep. Dec 2007. 30 (12):1788-94. [Medline].
Tom SE, Kuh D, Guralnik JM, Mishra GD. Self-reported sleep difficulty during the menopausal transition: results from a prospective cohort study. Menopause. 2010 Nov-Dec. 17(6):1128-35. [Medline].
Krystal AD. Depression and insomnia in women. Clin Cornerstone. 2004. 6 Suppl 1B:S19-28. [Medline].
Miller EH. Women and insomnia. Clin Cornerstone. 2004. 6 Suppl 1B:S8-18. [Medline].
Shin K, Shapiro C. Menopause, sex hormones, and sleep. Bipolar Disord. 2003 Apr. 5(2):106-9. [Medline].
Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 2003 Apr. 28 Suppl 2:17-54. [Medline].
Genazzani AR, Gambacciani M, Simoncini T, Schneider HP. Hormone replacement therapy in climacteric and aging brain. International Menopause Society Expert Workshop, 15-18 March 2003, Pisa, Italy. Climacteric. 2003 Sep. 6(3):188-203. [Medline].
Claudia P, Andrea C, Chiara C, Stefano L, Giuseppe M, Vincenzo DL. Panic disorder in menopause: a case control study. Maturitas. 2004 Jun 15. 48(2):147-54. [Medline].
Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD, et al. Prevalence and Correlates of Panic Attacks in Postmenopausal Women. Arch Intern Med. Sept 2003. 163:2041-47. [Medline].
Lochner C, Hemmings SM, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA. Corrigendum to "gender in obsessive-compulsive disorder: clinical and genetic findings" [Eur Neuropsychopharmacol 14 (2004) 105-13]. Eur Neuropsychopharmacol. 2004 Oct. 14(5):437-45. [Medline].
Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary Report. Journal of Psychiatric Research. 2008. 42:247-51. [Medline].
Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord. 2004 Feb. 6(1):2-13. [Medline].
Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003 Mar. 74(1):67-83. [Medline].
Halbreich U. Role of estrogen in postmenopausal depression. Neurology. 1997 May. 48(5 Suppl 7):S16-9. [Medline].
Soares, Claudio N. MD, PhD, FRCPC, MBA. Mood disorders in midlife women: understanding the critical window and its clinical implications. Menopause. February 2014. Volume 21 - Issue 2:p 198–206.
Huttner RP, Shepherd JE. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Med Clin North Am. 2003 Sep. 87(5):1065-76. [Medline].
Sloan DM, Kornstein SG. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am. 2003 Sep. 26(3):581-94. [Medline].
Charney DA, Stewart DE. Psychiatric aspects. Steward DE, Robinson GE, eds. A Clinician's Guide to Menopause. Washington, DC: Health Press International; 1997. 129-44.
Payne JL. The role of estrogen in mood disorders in women. Int Rev Psychiatry. 2003 Aug. 15(3):280-90. [Medline].
Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol. 2003 Aug 15. 158(4):347-56. [Medline].
Dennerstein L, Lehert P, Burger H, Dudley E. Mood and the menopausal transition. J Nerv Ment Dis. 1999 Nov. 187(11):685-91. [Medline].
Kessler RC. Epidemiology of women and depression. J Affect Disord. 2003 Mar. 74(1):5-13. [Medline].
Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry. 1979 May. 36(5):550-4. [Medline].
Dennerstein L, Guthrie JR, Clark M, Lehert P, Henderson VW. A population-based study of depressed mood in middle-aged, Australian-born women. Menopause. 2004 Sep-Oct. 11(5):563-8. [Medline].
Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996 Apr 6. 347(9006):930-3. [Medline].
Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000 Aug. 183(2):414-20. [Medline].
Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust. 1977 Jul 30. 2(5):162-3. [Medline].
Schneider HP. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med. 1997. 42 Suppl 2:365-75. [Medline].
Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 1997 Apr. 22(3):189-212. [Medline].
Amsterdam J, Garcia-España F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999 Sep. 55(1):11-7. [Medline].
Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry. 2003 Aug. 160(8):1519-22. [Medline].
Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA,. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA. 2002 Feb 6. 287(5):591-7. [Medline].
Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001 Jun. 58(6):529-34. [Medline].
Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas. 2005 Feb 14. 50(2):91-7. [Medline].
Schiff R, Bulpitt CJ, Wesnes KA, Rajkumar C. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology. 2005 May. 30(4):309-15. [Medline].
Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003 May 8. 348(19):1839-54. [Medline].
Heinrich AB, Wolf OT. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study. Neuropsychobiology. 2005. 52(1):17-23. [Medline].
Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA. 2003 Jun 4. 289(21):2827-34. [Medline].
Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011 Jan 19. 305(3):267-74. [Medline].
Hachul H, Brandao LC, D'Almeida V, Bittencourt LR, Baracat EC, Tufik S. Isoflavones decrease insomnia in postmenopause. Menopause. 2011 Feb. 18(2):178-84. [Medline].
Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004 Jun 23. 291(24):2959-68. [Medline].
Robinson GE, Stirtzinger R. Psychoeducational programs and support groups at transition to menopause. Steward DE, Robinson GE, eds. A Clinician's Guide to Menopause. Washington, DC: Health Press International; 1997. 165-80.
Michaud CM, Murray CJ, Bloom BR. Burden of disease--implications for future research. JAMA. 2001 Feb 7. 285(5):535-9. [Medline].
Bromberger JT, Kravitz HM, Chang YF, et al. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med. 2011 Sep. 41(9):1879-88. [Medline].
